Predictive Character Analysis of Ganglionic Echography for the Diagnostic of Benin or Malignant Superficial Adenopathy

NCT ID: NCT02645825

Last Updated: 2016-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-31

Study Completion Date

2019-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigators need to establish a formal diagnostic of superficial adenopathy through complementary investigations to find etiologic diagnostic ( Echography, adenogram).

Echography examination should be a guide to take in charge the adenopathy and to predict presence of malignant (primitive) or benin (reactional) character of adenopathy. The aim of this study is to codify the management of adenopathic patient with a diagnostic in 48 hours after examination. This fast diagnostic helps to prevent unnecessary biopsy, to avoid wasting time in case of a serious pathology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Superficial Adenopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- superficial adenopathy

Exclusion Criteria

\- obvious adenopathy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Berthou

Role: PRINCIPAL_INVESTIGATOR

CHRU de Brest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cabinet Brest

Brest, , France

Site Status NOT_YET_RECRUITING

Cabinet Brest

Brest, , France

Site Status NOT_YET_RECRUITING

Cabinet Brest

Brest, , France

Site Status NOT_YET_RECRUITING

Caninet Brest Centre

Brest, , France

Site Status NOT_YET_RECRUITING

CHRU de Brest

Brest, , France

Site Status RECRUITING

Cabinet Ergue Gaberic

Ergue Gaberit, , France

Site Status NOT_YET_RECRUITING

Cabinet Ergue Gaberit

Ergue Gaberit, , France

Site Status NOT_YET_RECRUITING

Cabinet Ergue Gaberic

Ergué-Gabéric, , France

Site Status NOT_YET_RECRUITING

Cabine Le Guivinec

Guilvinec, , France

Site Status NOT_YET_RECRUITING

Cabinet Le Guilvinec

Guilvinec, , France

Site Status NOT_YET_RECRUITING

Cabinet Le Guilvinec

Guilvinec, , France

Site Status NOT_YET_RECRUITING

Cabinet Lamneur

Lanmeur, , France

Site Status NOT_YET_RECRUITING

Cabinet Lanmeur

Lanmeur, , France

Site Status NOT_YET_RECRUITING

Cabinet Lanmeur

Lanmeur, , France

Site Status NOT_YET_RECRUITING

Cabinet Lanmeur

Lanmeur, , France

Site Status NOT_YET_RECRUITING

Cabinet Lanmeur

Lanmeur, , France

Site Status NOT_YET_RECRUITING

Cabinet Brest Centre

Le Relecq-Kerhuon, , France

Site Status NOT_YET_RECRUITING

Cabinet Lesconil

Lesconil, , France

Site Status NOT_YET_RECRUITING

Cabinet Penmarch

Penmarch, , France

Site Status NOT_YET_RECRUITING

Cabinet Plouegat Guerrand

Plouegat Guerrand, , France

Site Status NOT_YET_RECRUITING

Cabinet Quimper

Quimper, , France

Site Status NOT_YET_RECRUITING

CHIC Quimper

Quimper, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christian BERTHOU

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Patrick Balouet

Role: primary

Eric Furet

Role: primary

Dominique Nerriec

Role: primary

Pierre Barraine

Role: primary

Christian Berthou

Role: primary

Stéphane Primault

Role: primary

Jean-François Velly

Role: primary

Gilles De Chazal

Role: primary

Bernard Le Floch

Role: primary

Denis Barda

Role: primary

Dominique Le Bail

Role: primary

Jean-Yves Reste

Role: primary

Fabien Huiban

Role: primary

Joël Le Roc'h

Role: primary

Lise Le Roc'h-Gestin

Role: primary

Emilie Beck-Robert

Role: primary

Benoît Chiron

Role: primary

Jean-Jérôme Le Coq

Role: primary

Jannick Saliou

Role: primary

Daniel Le Floc'h

Role: primary

Nikan Mohtadi

Role: primary

Pascal Hutin

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EGAS - RB 14.077

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.